Related Experiment Video
Updated: Jun 11, 2026
22:10
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13.2K
Influenza B Virus Vaccine Innovation through Computational Design
Matthew J Pekarek1, Eric A Weaver1
1Nebraska Center for Virology, School of Biological Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA.
Pathogens (Basel, Switzerland)
|September 28, 2024
Summary
Influenza B viruses (IBVs) pose a growing threat, necessitating improved vaccines. This review explores IBV evolution, SARS-CoV-2 impacts, and promising computational vaccine design strategies for better prevention.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- Influenza B viruses (IBVs) are significant respiratory pathogens causing annual socioeconomic burden.
- Historically, IBVs were secondary to influenza A viruses (IAVs) in research due to lack of animal reservoirs.
- IBV epidemics became less predictable and more severe, especially in high-risk groups, prior to SARS-CoV-2.
Purpose of the Study:
- To review IBV evolutionary patterns and the impact of SARS-CoV-2 on these patterns.
- To analyze recent advancements in novel vaccine development against IBVs.
- To highlight the potential of computational vaccine design for IBVs and IAVs.
Main Methods:
- Literature review of IBV evolutionary patterns.
- Analysis of recent scientific literature on IBV vaccine development.
- Examination of computational vaccine design strategies.
Main Results:
- IBV epidemics show increasing unpredictability and severity.
- SARS-CoV-2 has influenced IBV patterns.
- Computational vaccine design shows promise for targeting both IBVs and IAVs.
Conclusions:
- Improved prevention strategies for IBVs are crucial.
- Novel vaccine development, particularly using computational approaches, offers a promising path forward.
- Targeting both IBVs and IAVs with advanced vaccine design can enhance effectiveness.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...